| Pharmaids Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524572 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE117D01018 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 15.14 |
Market Cap(₹Cr) : 105.73 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.00 | 2.69 | 0.83 | 5.97 | 1.12 | 0.13 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.00 | 2.69 | 0.83 | 5.97 | 1.12 | 0.13 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 4.25 | 0.06 | 0.06 | 3.32 | 0.35 | 1.01 |
| Total Income | 4.25 | 2.75 | 0.89 | 9.29 | 1.46 | 1.14 |
| Total Expenditure | 0.87 | 3.79 | 4.51 | 10.54 | 5.99 | 2.81 |
| PBIDT | 3.38 | -1.04 | -3.61 | -1.26 | -4.53 | -1.68 |
| Interest | 0.57 | 0.60 | 0.57 | 1.02 | 1.11 | 2.05 |
| PBDT | 2.80 | -1.64 | -4.18 | -2.28 | -5.64 | -3.73 |
| Depreciation | 0.06 | 0.05 | 0.05 | 0.06 | 0.05 | 0.05 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.61 | -0.38 | -1.13 | -0.68 | -1.33 | -0.72 |
| Reported Profit After Tax | 2.13 | -1.31 | -3.11 | -1.65 | -4.36 | -3.06 |
| Extra-ordinary Items | 3.59 | -0.02 | 0.00 | 3.13 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -1.46 | -1.29 | -3.11 | -4.78 | -4.36 | -3.06 |
| EPS (Unit Curr.) | 0.61 | -0.37 | -0.88 | -0.47 | -1.24 | -0.86 |
| EPS (Adj) (Unit Curr.) | 0.61 | -0.37 | -0.88 | -0.47 | -1.24 | -0.86 |
| Calculated EPS (Unit Curr.) | 0.61 | -0.37 | -0.88 | -0.47 | -1.24 | -0.87 |
| Calculated EPS (Adj) (Unit Curr.) | 0.61 | -0.37 | -0.88 | -0.47 | -1.24 | -0.87 |
| Calculated EPS (Ann.) (Unit Curr.) | 2.42 | -1.49 | -3.53 | -1.87 | -4.95 | -3.47 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.42 | -1.49 | -3.53 | -1.87 | -4.95 | -3.47 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 35.27 | 35.27 | 35.27 | 35.27 | 35.27 | 35.27 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 22.51 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 0.00 | -38.66 | -434.94 | -21.11 | -404.46 | -1,292.31 |
| PBDTM(%) | 0.00 | -60.97 | -503.61 | -38.19 | -503.57 | -2,869.23 |
| PATM(%) | 0.00 | -48.70 | -374.70 | -27.64 | -389.29 | -2,353.85 |
